ContractClinical Trial Agreement • January 13th, 2022
Contract Type FiledJanuary 13th, 2022Amendment # 2 Dodatek č. 2 to Clinical Trial Agreement Ke Smlouvě o klinické studii Protocol No. Č. protokolu This amendment (“Amendment”) is made by Tento dodatek („Dodatek“) vydává Celgene Corporation, having its principal office at 86 Morris Avenue, Summit, NJ 07901, USA represented for the purposes of this Amendment by Celgene International II Sàrl, a limited liability company organized under the laws of Switzerland having its principal office at Route de Perreux 1, 2017 Boudry, Switzerland (hereinafter the “Sponsor”)For the only purposes of signing this Amendment the Sponsor is represented by PPD Investigator Services LLC, a company organized under the laws of the State of Delaware having its principal office at 929 North Front Street, Wilmington NC 28401, USA. Celgene Corporation se sídlem na adrese 86 Morris Avenue, Summit, NJ 07901, USA zastoupená pro účely tohoto dodatku Celgene International II Sàrl, společností s ručením omezeným zřízenou podle švýcarských právních předpisů